Silver Book Fact

A new study reports that using optogenetics, stimulating specific brain cells using light, may provide better results for Parkinson’s patients than traditional deep brain stimulation because of the ability to control different cells at specific times.

Gradinaru V, Mogri M, Thompson K, Henderson J, et al. Optical Deconstruction of Parkinsonian Neural Circuitry. Science. 2009; 324(5925): 354-9. http://www.ncbi.nlm.nih.gov/pubmed/19299587

Reference

Title
Optical Deconstruction of Parkinsonian Neural Circuitry
Publication
Science
Publication Date
2009
Authors
Gradinaru V, Mogri M, Thompson K, Henderson J, et al.
Volume & Issue
Volume 324, Issue 5925
Pages
354-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • 91 medicines are currently in development for Alzheimer’s disease.  
  • Willena is 75 and was diagnosed with Alzheimer’s disease five years ago Her daughter and primary caregiver, Wanda
    “Willena is 75 and was diagnosed with Alzheimer’s disease five years ago. Her daughter and primary caregiver, Wanda Richardson, believes that her mother went undiagnosed for at least 15 years…  
  • The present value QUALY gains associated with a new drug that by 2010 could delay disease onset by 1, 3, and 5 years. The dollar value estimates range from approximately…  
  • A treatment breakthrough that slowed the progression of Alzheimer’s disease would reduce the number of people with the disease from 2.4 million to 1.1 million in 2020, and from 6.5…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 out-of-pocket costs for individuals and families dealing with the…